Exact Mass: 551.2188912
Exact Mass Matches: 551.2188912
Found 140 metabolites which its exact mass value is equals to given mass value 551.2188912
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Astin I
C25H34ClN5O7 (551.2146644000001)
Astin I is found in fruits. Astin I is a constituent of Actinidia kolomikta (kiwi fruit). Constituent of Actinidia kolomikta (kiwi fruit). Astin I is found in fruits.
4-Hydroxytamoxifen-N-glucuronide
4-Hydroxytamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
Saredutant
(+)-8beta-(4-hydroxybenzyl)-2-methoxy-10-O-(beta-xylopyranosyl)berbin-3,11-diol|(+)-8beta-<4-hydroxybenzyl>-2-methoxy-10-O-berbin-3,11-diol|O10-beta-Xylopyranoside-8-(4-Hydroxybenzyl)-2-methoxy-3,10,11-berbintriol
(+)-8alpha-(4-hydroxybenzyl)-2-methoxy-10-O-(beta-xylopyranosyl)berbin-3,9-diol|(+)-8alpha-<4-hydroxybenzyl>-2-methoxy-10-O-berbin-3,9-diol
Cys Phe Pro Trp
C28H33N5O5S (551.2202288000001)
Cys Phe Trp Pro
C28H33N5O5S (551.2202288000001)
Cys Ile Met Trp
C25H37N5O5S2 (551.2235992000001)
Cys Ile Trp Met
C25H37N5O5S2 (551.2235992000001)
Cys Leu Met Trp
C25H37N5O5S2 (551.2235992000001)
Cys Leu Trp Met
C25H37N5O5S2 (551.2235992000001)
Cys Met Ile Trp
C25H37N5O5S2 (551.2235992000001)
Cys Met Leu Trp
C25H37N5O5S2 (551.2235992000001)
Cys Met Trp Ile
C25H37N5O5S2 (551.2235992000001)
Cys Met Trp Leu
C25H37N5O5S2 (551.2235992000001)
Cys Pro Phe Trp
C28H33N5O5S (551.2202288000001)
Cys Pro Trp Phe
C28H33N5O5S (551.2202288000001)
Cys Trp Phe Pro
C28H33N5O5S (551.2202288000001)
Cys Trp Ile Met
C25H37N5O5S2 (551.2235992000001)
Cys Trp Leu Met
C25H37N5O5S2 (551.2235992000001)
Cys Trp Met Ile
C25H37N5O5S2 (551.2235992000001)
Cys Trp Met Leu
C25H37N5O5S2 (551.2235992000001)
Cys Trp Pro Phe
C28H33N5O5S (551.2202288000001)
Asp Met Met Arg
Asp Met Arg Met
Asp Arg Met Met
Glu Glu Phe Gln
Glu Glu Gln Phe
Glu Phe Glu Gln
Glu Phe Gln Glu
Glu Gln Glu Phe
Glu Gln Phe Glu
Phe Cys Pro Trp
C28H33N5O5S (551.2202288000001)
Phe Cys Trp Pro
C28H33N5O5S (551.2202288000001)
Phe Glu Glu Gln
Phe Glu Gln Glu
Phe Pro Cys Trp
C28H33N5O5S (551.2202288000001)
Phe Pro Trp Cys
C28H33N5O5S (551.2202288000001)
Phe Gln Glu Glu
Phe Trp Cys Pro
C28H33N5O5S (551.2202288000001)
Phe Trp Pro Cys
C28H33N5O5S (551.2202288000001)
His His Met Gln
C22H33N9O6S (551.2274398000001)
His His Gln Met
C22H33N9O6S (551.2274398000001)
His Met His Gln
C22H33N9O6S (551.2274398000001)
His Met Gln His
C22H33N9O6S (551.2274398000001)
His Gln His Met
C22H33N9O6S (551.2274398000001)
His Gln Met His
C22H33N9O6S (551.2274398000001)
Ile Cys Met Trp
C25H37N5O5S2 (551.2235992000001)
Ile Cys Trp Met
C25H37N5O5S2 (551.2235992000001)
Ile Met Cys Trp
C25H37N5O5S2 (551.2235992000001)
Ile Met Trp Cys
C25H37N5O5S2 (551.2235992000001)
Ile Trp Cys Met
C25H37N5O5S2 (551.2235992000001)
Ile Trp Met Cys
C25H37N5O5S2 (551.2235992000001)
Leu Cys Met Trp
C25H37N5O5S2 (551.2235992000001)
Leu Cys Trp Met
C25H37N5O5S2 (551.2235992000001)
Leu Met Cys Trp
C25H37N5O5S2 (551.2235992000001)
Leu Met Trp Cys
C25H37N5O5S2 (551.2235992000001)
Leu Trp Cys Met
C25H37N5O5S2 (551.2235992000001)
Leu Trp Met Cys
C25H37N5O5S2 (551.2235992000001)
Met Cys Ile Trp
C25H37N5O5S2 (551.2235992000001)
Met Cys Leu Trp
C25H37N5O5S2 (551.2235992000001)
Met Cys Trp Ile
C25H37N5O5S2 (551.2235992000001)
Met Cys Trp Leu
C25H37N5O5S2 (551.2235992000001)
Met Asp Met Arg
Met Asp Arg Met
Met His His Gln
C22H33N9O6S (551.2274398000001)
Met His Gln His
C22H33N9O6S (551.2274398000001)
Met Ile Cys Trp
C25H37N5O5S2 (551.2235992000001)
Met Ile Trp Cys
C25H37N5O5S2 (551.2235992000001)
Met Leu Cys Trp
C25H37N5O5S2 (551.2235992000001)
Met Leu Trp Cys
C25H37N5O5S2 (551.2235992000001)
Met Met Asp Arg
Met Met Arg Asp
Met Gln His His
C22H33N9O6S (551.2274398000001)
Met Arg Asp Met
Met Arg Met Asp
Met Trp Cys Ile
C25H37N5O5S2 (551.2235992000001)
Met Trp Cys Leu
C25H37N5O5S2 (551.2235992000001)
Met Trp Ile Cys
C25H37N5O5S2 (551.2235992000001)
Met Trp Leu Cys
C25H37N5O5S2 (551.2235992000001)
Pro Cys Phe Trp
C28H33N5O5S (551.2202288000001)
Pro Cys Trp Phe
C28H33N5O5S (551.2202288000001)
Pro Phe Cys Trp
C28H33N5O5S (551.2202288000001)
Pro Phe Trp Cys
C28H33N5O5S (551.2202288000001)
Pro Trp Cys Phe
C28H33N5O5S (551.2202288000001)
Pro Trp Phe Cys
C28H33N5O5S (551.2202288000001)
Gln Glu Glu Phe
Gln Glu Phe Glu
Gln Phe Glu Glu
Gln His His Met
C22H33N9O6S (551.2274398000001)
Gln His Met His
C22H33N9O6S (551.2274398000001)
Gln Met His His
C22H33N9O6S (551.2274398000001)
Arg Asp Met Met
Arg Met Asp Met
Arg Met Met Asp
Trp Cys Phe Pro
C28H33N5O5S (551.2202288000001)
Trp Cys Ile Met
C25H37N5O5S2 (551.2235992000001)
Trp Cys Leu Met
C25H37N5O5S2 (551.2235992000001)
Trp Cys Met Ile
C25H37N5O5S2 (551.2235992000001)
Trp Cys Met Leu
C25H37N5O5S2 (551.2235992000001)
Trp Cys Pro Phe
C28H33N5O5S (551.2202288000001)
Trp Phe Cys Pro
C28H33N5O5S (551.2202288000001)
Trp Phe Pro Cys
C28H33N5O5S (551.2202288000001)
Trp Ile Cys Met
C25H37N5O5S2 (551.2235992000001)
Trp Ile Met Cys
C25H37N5O5S2 (551.2235992000001)
Trp Leu Cys Met
C25H37N5O5S2 (551.2235992000001)
Trp Leu Met Cys
C25H37N5O5S2 (551.2235992000001)
Trp Met Cys Ile
C25H37N5O5S2 (551.2235992000001)
Trp Met Cys Leu
C25H37N5O5S2 (551.2235992000001)
Trp Met Ile Cys
C25H37N5O5S2 (551.2235992000001)
Trp Met Leu Cys
C25H37N5O5S2 (551.2235992000001)
Trp Pro Cys Phe
C28H33N5O5S (551.2202288000001)
Trp Pro Phe Cys
C28H33N5O5S (551.2202288000001)
2,6-DIPHENYL-4-(2,4,6-TRIPHENYL-1-PYRIDINIO)PHENOLATE
N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
Saredutant
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Saredutant is a selective NK2 receptor antagonist.
[(2S,3R,4R,5R,6S)-4-(dimethylamino)-5-hydroxy-6-(1-hydroxy-10,12-dimethoxy-8-methyl-6-oxonaphtho[1,2-c]isochromen-4-yl)-2-methyloxan-3-yl] acetate
[(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(2-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-morpholinyl)methanone
C30H34FN3O4S (551.2253936000001)
[(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(2-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-morpholin-4-ylmethanone
C30H34FN3O4S (551.2253936000001)
2-[(2R,9S,12R,13R,15S)-15-[(E)-hex-4-enoyl]-12-[(E)-oct-6-enyl]-4,6,18-trioxo-5,16,17-trioxapentacyclo[7.7.2.01,10.02,13.03,7]octadeca-3(7),10-dien-9-yl]acetate
N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin
C29H33N3O8 (551.2267538000001)
Coumarin carrying a methyl group at C-4 and a succinyl-leucyl-tryrosyl side-chain at C-7.
(2s,3s,6s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (2s,3r)-3-benzyl-2,3-dihydroxybutanedioate
(3s,6s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (2s,3r)-3-benzyl-2,3-dihydroxybutanedioate
(2s,3s,4r,5s)-4-[(acetyloxy)methyl]-2,5-bis(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]oxolane-3-carboximidic acid
10-{[1,9-dihydroxy-2-(2-methylpropyl)-3-oxo-2h,9ah-imidazo[1,2-a]indol-9-yl]methyl}-8-hydroxy-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one
(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (2s,3r)-3-benzyl-2,3-dihydroxybutanedioate
17-chloro-3,13-diethyl-1,4,7,11,18-pentahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H34ClN5O7 (551.2146644000001)